STEPHANIE WALLACE: Open Payments
NPI 1730419599 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 59 payments from 14 companies in 2025. Trend: 2023 $1,675 · 2024 $1,598 · 2025 $1,516
Food & beverage: $1,482Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $538 |
| Regeneron Healthcare Solutions, Inc. | 9 | $209 |
| Novartis Pharmaceuticals Corporation | 9 | $202 |
| GENZYME CORPORATION | 1 | $150 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| CSL Behring | 4 | $78 |
| Amgen Inc. | 3 | $62 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $57 |
| PFIZER INC. | 1 | $24 |
| Grifols USA, LLC | 1 | $19 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, AIRSUPRA, NEFFY, NUCALA, TRELEGY ELLIPTA, Rhapsido.
Industry payments across KY — which companies pay providers there.
